164 related articles for article (PubMed ID: 34764241)
1. Phosphoproteomics reveals therapeutic targets of esophageal squamous cell carcinoma.
Li Y; Yang B; Ma Y; Peng X; Wang Z; Sheng B; Wei Z; Cui Y; Liu Z
Signal Transduct Target Ther; 2021 Nov; 6(1):381. PubMed ID: 34764241
[No Abstract] [Full Text] [Related]
2. MiR-155 promotes the migration and invasion of esophageal squamous cell carcinoma via downregulating PTEN.
Zhang J; Meng L; Yu P; Li J; Yu J
Minerva Med; 2021 Feb; 112(1):155-157. PubMed ID: 31282135
[No Abstract] [Full Text] [Related]
3. Depletion of LAMP3 enhances PKA-mediated VASP phosphorylation to suppress invasion and metastasis in esophageal squamous cell carcinoma.
Huang F; Ma G; Zhou X; Zhu X; Yu X; Ding F; Cao X; Liu Z
Cancer Lett; 2020 Jun; 479():100-111. PubMed ID: 32200035
[TBL] [Abstract][Full Text] [Related]
4. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
[TBL] [Abstract][Full Text] [Related]
5. [Expression of PLOD2 in esophageal squamous cell carcinoma and its correlation with invasion and metastasis].
Di WY; Kang XH; Zhang JH; Wang Y; Kou WZ; Su W
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):102-107. PubMed ID: 30695860
[No Abstract] [Full Text] [Related]
6. The protein-protein interaction network and clinical significance of heat-shock proteins in esophageal squamous cell carcinoma.
Sun H; Cai X; Zhou H; Li X; Du Z; Zou H; Wu J; Xie L; Cheng Y; Xie W; Lu X; Xu L; Chen L; Li E; Wu B
Amino Acids; 2018 Jun; 50(6):685-697. PubMed ID: 29700654
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
[TBL] [Abstract][Full Text] [Related]
8. Stromal interaction molecule 1 promotes tumor growth in Esophageal squamous cell carcinoma.
Tang J; Ye S; Wang M; Li J; Meng X; Liu F
Genomics; 2020 May; 112(3):2146-2153. PubMed ID: 31843504
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.
Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y
Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 and PD-L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma.
Okadome K; Baba Y; Yasuda-Yoshihara N; Nomoto D; Yagi T; Toihata T; Ogawa K; Sawayama H; Ishimoto T; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Komohara Y; Baba H
Cancer Sci; 2022 Feb; 113(2):399-410. PubMed ID: 34773342
[TBL] [Abstract][Full Text] [Related]
11. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI
Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
13. HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma.
Wu Y; Yang Y; Xian YS
Chem Biol Interact; 2019 Aug; 308():357-363. PubMed ID: 31152734
[TBL] [Abstract][Full Text] [Related]
14. NEDD8-conjugating enzyme UBC12 as a novel therapeutic target in esophageal squamous cell carcinoma.
Wang S; Xian J; Li L; Jiang Y; Liu Y; Cai L; Hoffman RM; Jia L; Zhao H; Zhang Y
Signal Transduct Target Ther; 2020 Jul; 5(1):123. PubMed ID: 32651357
[No Abstract] [Full Text] [Related]
15. MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6.
Wei L; Wang B; Hu L; Xu Y; Li Z; Shen Y; Huang H
Aging (Albany NY); 2020 Nov; 12(21):21091-21113. PubMed ID: 33188661
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein family B member 1 facilitates ezrin activation to control cell migration in esophageal squamous cell carcinoma.
Xie YH; Li LY; He JZ; Xu XE; Liao LD; Zhang Q; Xie JJ; Xu LY; Li EM
Int J Biochem Cell Biol; 2019 Jul; 112():79-87. PubMed ID: 31082616
[TBL] [Abstract][Full Text] [Related]
18. Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma.
Baba Y; Nomoto D; Okadome K; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Baba H
Cancer Sci; 2020 Sep; 111(9):3132-3141. PubMed ID: 32579769
[TBL] [Abstract][Full Text] [Related]
19. A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage.
Ye J; Ma J; Liu C; Huang J; Wang L; Zhong X
Biochem Pharmacol; 2019 Aug; 166():93-107. PubMed ID: 31078603
[TBL] [Abstract][Full Text] [Related]
20. Complex role of miR-130a-3p and miR-148a-3p balance on drug resistance and tumor biology in esophageal squamous cell carcinoma.
Eichelmann AK; Matuszcak C; Lindner K; Haier J; Hussey DJ; Hummel R
Sci Rep; 2018 Dec; 8(1):17553. PubMed ID: 30510209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
